Fresenius And Formycon File Ustekinumab In Europe

Application For FYB202 Biosimilar Rival To Stelara Is Accepted By EMA

 
• By David Wallace
  
EMA
The ustekinumab filing has been accepted by the EMA

More from Biosimilars

More from Products